drugset
drugset / Trial / NCT05934825

Clinical Trial to Evaluate Safety and Efficiency of Mesenchymal Stem Cell in Patients With Hidradenitis Suppurativa

NCT05934825 ↗

Phase 1/2 Unknown 30 enrolled Andalusian Network for Design and Translation of Advanced Therapies
RandomizedParallel-groupDouble-blindTreatment

Summary

Multicenter Phase I/II Clinical Trial to Evaluate Safety and Efficiency of Allogenic Adult Mesenchymal Stem Cell from Adipose Tissue in Patients With Hidradenitis Suppurativa

Timeline

Start
2022-10-26
Primary completion
2025-10-26
Completion
2025-10-26

Drugs

EvaluationDrugModalityDoseRoute
Subject allogeneic adult mesenchymal stem cells Unknown 1.2e+08 cells Other

Indications

hidradenitis suppurativa